Purpose
to determine whether triple drug therapy for lymphatic filariasis can be safely used in persons with onchocerciasis following a clearing dose of ivermectin
Grantee
Division
Global Health
Date
APRIL 2018
Region served
AFRICA
Committed amount
$2,653,723
Grant topic
Neglected Tropical Diseases
Duration (months)
59
Grantee location
St. Louis, Missouri, United States
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.